MX2023003426A - Epítopos de celulas t reguladoras retro-inversas. - Google Patents
Epítopos de celulas t reguladoras retro-inversas.Info
- Publication number
- MX2023003426A MX2023003426A MX2023003426A MX2023003426A MX2023003426A MX 2023003426 A MX2023003426 A MX 2023003426A MX 2023003426 A MX2023003426 A MX 2023003426A MX 2023003426 A MX2023003426 A MX 2023003426A MX 2023003426 A MX2023003426 A MX 2023003426A
- Authority
- MX
- Mexico
- Prior art keywords
- inverso
- retro
- regulatory
- cell epitopes
- tregitope
- Prior art date
Links
- 210000003289 regulatory T cell Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083392P | 2020-09-25 | 2020-09-25 | |
| PCT/US2021/052017 WO2022067076A1 (en) | 2020-09-25 | 2021-09-24 | Retro-inverso regulatory t cell epitopes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023003426A true MX2023003426A (es) | 2023-04-27 |
Family
ID=80845816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023003426A MX2023003426A (es) | 2020-09-25 | 2021-09-24 | Epítopos de celulas t reguladoras retro-inversas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240173377A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4216984A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023543801A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230074517A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021350011A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3193819A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023003426A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022067076A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM411994A0 (en) * | 1994-02-25 | 1994-03-24 | Deakin Research Limited | Epitopes |
| EP2423220B1 (en) * | 2007-01-30 | 2015-04-29 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| WO2012142022A1 (en) * | 2011-04-11 | 2012-10-18 | The General Hospital Corporation | Assays, compositions, systems, kits, and devices for diagnosing typhoid fever |
| SG11201810470XA (en) * | 2016-06-10 | 2018-12-28 | Eisai R&D Man Co Ltd | Lysine conjugated immunoglobulins |
| JP7274472B2 (ja) * | 2017-10-05 | 2023-05-16 | エピバックス、インコーポレイテッド | 制御性t細胞エピトープ |
-
2021
- 2021-09-24 US US18/044,876 patent/US20240173377A1/en active Pending
- 2021-09-24 WO PCT/US2021/052017 patent/WO2022067076A1/en not_active Ceased
- 2021-09-24 JP JP2023519066A patent/JP2023543801A/ja active Pending
- 2021-09-24 AU AU2021350011A patent/AU2021350011A1/en not_active Abandoned
- 2021-09-24 CA CA3193819A patent/CA3193819A1/en active Pending
- 2021-09-24 MX MX2023003426A patent/MX2023003426A/es unknown
- 2021-09-24 EP EP21873543.9A patent/EP4216984A4/en active Pending
- 2021-09-24 KR KR1020237013399A patent/KR20230074517A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA3193819A1 (en) | 2022-03-31 |
| AU2021350011A1 (en) | 2023-05-11 |
| EP4216984A4 (en) | 2025-03-05 |
| KR20230074517A (ko) | 2023-05-30 |
| AU2021350011A9 (en) | 2025-03-13 |
| EP4216984A1 (en) | 2023-08-02 |
| WO2022067076A1 (en) | 2022-03-31 |
| JP2023543801A (ja) | 2023-10-18 |
| US20240173377A1 (en) | 2024-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202308519B (en) | Anti-vegf protein compositions and methods for producing the same | |
| TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
| MX2021001706A (es) | Compuestos de anillo fusionado. | |
| MX2020012797A (es) | Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso. | |
| MY205789A (en) | Anti-gdf15 antibodies, compositions and methods of use | |
| PH12018502535B1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| PH12019550235A1 (en) | Kinase inhibitors and uses thereof | |
| MX2020005478A (es) | Compuestos de sulfonamida y usos de los mismos. | |
| PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
| CR20150491A (es) | 3-pirimidin-4-il oxazolidin -2- onas como inhibidores de idh mutante | |
| MY187449A (en) | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl | |
| MX2015017103A (es) | Celulas beta derivadas de células madre ( sc-beta ) y composiciones y métodos para generarlas. | |
| UY34418A (es) | Compuestos derivados de la piridopiracina, su preparación, composiciones que los contienen y su uso en terapia | |
| EP4368641A3 (en) | Kappa myeloma antigen chimeric antigen receptors and uses thereof | |
| WO2021127200A8 (en) | Ilt3-binding agents and methods of use thereof | |
| MX2015011436A (es) | Triazolopiridinas sustituidas y metodos para usarlas. | |
| MX2021003180A (es) | Métodos y kits para preparar sangre entera con inactivación de patógenos. | |
| ZA202309516B (en) | Anti-ccr8 antibodies | |
| PH12016500972A1 (en) | Moisture-resistant phosphor compositions and associate methods | |
| ZA201905895B (en) | Kits and methods for preparing pathogen-inactivated platelet compositions | |
| MX2021008834A (es) | Metodos de tratamiento del cancer de mama con tucatinib. | |
| CR20200202A (es) | Metodos de uso y composiciones que contienen dulaglutida | |
| MX2021002286A (es) | Terapias de combinacion. | |
| MX2020002045A (es) | Composicion herbicida. | |
| SA521431223B1 (ar) | Angpt2 أجسام مضادة لـ |